Scientific and Regulatory Writing Services
Aclairo’s regulatory and scientific writers have extensive experience in researching and writing nonclinical and clinical study reports, successful regulatory documents, and position papers.
Scientific and Regulatory Writing Services
Aclairo’s scientific and regulatory writing services support the preparation of high-quality, submission-ready documents required for regulatory interactions and scientific communication. These documents must meet strict expectations from global health authorities, including the FDA and international agencies, while accurately reflecting complex scientific data.
We will work with you to meet your specifications and timelines using your templates and style guide, or our own, to create submission-ready documents. We ensure adherence to relevant guidances for global health authorities, provide consistently high-quality documents, and conduct a quality control (QC) review of each document. We never use artificial intelligence to create scientific or regulatory documents unless specifically requested by the client.
When Are Scientific and Regulatory Writing Services Needed?
Regulatory writing services are essential throughout drug development, from early planning through regulatory submission.
Expertise in Scientific and Regulatory Writing
What sets Aclairo apart is the depth of our expertise. Our writers bring decades of combined hands-on technical toxicology experience and writing proficiency, ensuring that every project benefits from the best knowledge in the field.
Aclairo writers routinely prepare:- Regulatory submissions for FDA, Canada, Australia, New Zealand, MHRA, Europe, and Asia
- Special protocol assessments (SPAs)
- Nonclinical sections of Investigator Brochures (IBs)
- INDs, CTAs, BLAs, and NDAs
- Pharmacology reports based on sponsor data
- Technical and scientific review and QC checks of regulatory applications
- Primary research manuscripts, position papers and white papers for preclinical, DMPK, and clinical research publications
- Clinical pharmacology summaries and reports
- Literature reviews and summaries
- Carcinogenicity Risk Assessments and Study Waivers
- Target Liability Assessments
- Subject-specific literature searches
- GLP study reports
- FDA meeting packages
- INTERACT
- Pre-IND
- Pre-NDA/BLA
Our Scientific and Regulatory Writing Process
- Initial scope definition and document planning
- Review of source data and background materials
- Draft development aligned with regulatory expectations
- Internal scientific and QC review
- Sponsor review and comment resolution
- Finalization and delivery of submission-ready documents
Related Services
This is where we add links to related articles, posts, or services pages
Frequently Asked Questions
- What types of regulatory documents can you support? We support a wide range of regulatory and scientific documents, including INDs, NDAs, BLAs, CTAs, Investigator Brochures, pharmacology reports, DMPK and Clinical Pharmacology reports, and FDA meeting packages.
- Do you follow FDA and international guidelines? Yes, all documents are developed in alignment with relevant guidances from FDA and global health authorities.
- Do you use artificial intelligence to write documents? We never use artificial intelligence to create scientific or regulatory documents unless specifically requested by the client.
- Can you work within our templates and style guides? Yes, Aclairo uses industry standard document templates; however, we routinely work with client style guides and templates as desired.